文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Mapping the ethical landscape of digital biomarkers: A scoping review.

作者信息

Andreoletti Mattia, Haller Luana, Vayena Effy, Blasimme Alessandro

机构信息

Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.

出版信息

PLOS Digit Health. 2024 May 16;3(5):e0000519. doi: 10.1371/journal.pdig.0000519. eCollection 2024 May.

DOI:10.1371/journal.pdig.0000519
PMID:38753605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11098308/
Abstract

In the evolving landscape of digital medicine, digital biomarkers have emerged as a transformative source of health data, positioning them as an indispensable element for the future of the discipline. This necessitates a comprehensive exploration of the ethical complexities and challenges intrinsic to this cutting-edge technology. To address this imperative, we conducted a scoping review, seeking to distill the scientific literature exploring the ethical dimensions of the use of digital biomarkers. By closely scrutinizing the literature, this review aims to bring to light the underlying ethical issues associated with the development and integration of digital biomarkers into medical practice.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/aa60104beb05/pdig.0000519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/0493d2ef72c8/pdig.0000519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/1464442da9cb/pdig.0000519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/aa60104beb05/pdig.0000519.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/0493d2ef72c8/pdig.0000519.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/1464442da9cb/pdig.0000519.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4478/11098308/aa60104beb05/pdig.0000519.g003.jpg

相似文献

[1]
Mapping the ethical landscape of digital biomarkers: A scoping review.

PLOS Digit Health. 2024-5-16

[2]
Identifying facilitators of and barriers to the adoption of dynamic consent in digital health ecosystems: a scoping review.

BMC Med Ethics. 2023-12-1

[3]
Exploring the ethical issues in research using digital data collection strategies with minors: A scoping review.

PLoS One. 2020-8-27

[4]
Exploring the Risks, Benefits, Advances, and Challenges in Internet Integration in Medicine With the Advent of 5G Technology: A Comprehensive Review.

Cureus. 2023-11-13

[5]
PROFESSIONAL ETHICS OF PUBLIC RELATIONS PRACTITIONERS IN THE CONTEXT OF DIGITALIZATION.

Georgian Med News. 2024-4

[6]
Current ethical and social issues in epidemiology.

Ann Epidemiol. 2023-4

[7]
The metaverse digital environments: a scoping review of the challenges, privacy and security issues.

Front Big Data. 2023-11-23

[8]
Exploring Online Health Information Seeking Behaviour (OHISB) among young adults: A scoping review protocol.

BMJ Open. 2024-1-30

[9]
Ethical and legal challenges in nanomedical innovations: a scoping review.

Front Genet. 2023-5-12

[10]
Mapping Digital Public Health Interventions Among Existing Digital Technologies and Internet-Based Interventions to Maintain and Improve Population Health in Practice: Scoping Review.

J Med Internet Res. 2024-7-17

引用本文的文献

[1]
Advancing the Integration of Digital Health Technologies in the Drug Development Ecosystem.

J Med Internet Res. 2025-7-31

[2]
The implementation of digital biomarkers in the diagnosis, treatment and monitoring of mood disorders: a narrative review.

Front Digit Health. 2025-6-17

[3]
Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI.

Diagnostics (Basel). 2025-5-13

[4]
Biomarker-Driven Approaches to Bone Metastases: From Molecular Mechanisms to Clinical Applications.

Biomedicines. 2025-5-10

[5]
Monitoring oral health remotely: ethical considerations when using AI among vulnerable populations.

Front Oral Health. 2025-4-14

[6]
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment.

Biomark Med. 2025-3

[7]
Beyond clinical observations: a scoping review of AI-detectable observable cues in borderline personality disorder.

Front Psychiatry. 2024-12-10

[8]
A Comprehensive Review of Biomarkers for Chronic Kidney Disease in Older Individuals: Current Perspectives and Future Directions.

Cureus. 2024-9-26

[9]
The risks of artificial intelligence: A narrative review and ethical reflection from an Oral Medicine group.

Oral Dis. 2025-2

本文引用的文献

[1]
Ethical issues when using digital biomarkers and artificial intelligence for the early detection of dementia.

Wiley Interdiscip Rev Data Min Knowl Discov. 2023

[2]
Digital phenotyping could help detect autism.

Nat Med. 2023-10

[3]
The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?

Biosens Bioelectron. 2023-9-1

[4]
Decentralised clinical trials: ethical opportunities and challenges.

Lancet Digit Health. 2023-6

[5]
Stuck in translation: Stakeholder perspectives on impediments to responsible digital health.

Front Digit Health. 2023-2-6

[6]
Associations between smartphone keystroke dynamics and cognition in MS.

Digit Health. 2022-12-5

[7]
Developments in scalable strategies for detecting early markers of cognitive decline.

Transl Psychiatry. 2022-11-9

[8]
Digital Biomarker-Based Studies: Scoping Review of Systematic Reviews.

JMIR Mhealth Uhealth. 2022-10-24

[9]
The value of companion diagnostics in oncology drug development.

Expert Rev Mol Diagn. 2022-6

[10]
Digital Biomarkers in Psychiatric Research: Data Protection Qualifications in a Complex Ecosystem.

Front Psychiatry. 2022-6-9

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索